Logo image
Correction to: Cost-utility analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: From randomised trial to real world
Journal article   Open access   Peer reviewed

Correction to: Cost-utility analysis of Lopinavir/Ritonavir versus Atazanavir + Ritonavir administered as first-line therapy for the treatment of HIV infection in Italy: From randomised trial to real world

Emanuela Foglia, Paolo Bonfanti, Giuliano Rizzardini, Erminio Bonizzoni, Umberto Restelli, Elena Ricci, Emanuele Porazzi, Francesca Scolari and Davide Croce
PloS one, Vol.9(1), 234
2014
Scopus ID: 2-s2.0-84896792296
Web of Science ID: WOS:000315519000160
PMCID: PMC3880403
url
https://doi.org/10.1371/annotation/e57d7e73-826c-4e1c-a7c6-d2c32d3809afView
Published (Version of record) Open

Metrics

1 Record Views

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being
Logo image